Lysosomal Storage Disorders in the Newborn

Overview

Journal Pediatrics

Specialty Pediatrics

Date 2009 Apr 2

PMID 19336380

Citations 54

Authors

Orna Staretz-Chacham

Tess C Lang

Mary E Lamarca

Donna Krasnewich

Ellen Sidransky

Affiliations

Soon will be listed here.

Abstract

Lysosomal storage disorders are rare inborn errors of metabolism, with a combined incidence of 1 in 1500 to 7000 live births. These relatively rare disorders are seldom considered when evaluating a sick newborn. A significant number of the >50 different lysosomal storage disorders, however, do manifest in the neonatal period and should be part of the differential diagnosis of several perinatal phenotypes. We review the earliest clinical features, diagnostic tests, and treatment options for lysosomal storage disorders that can present in the newborn. Although many of the lysosomal storage disorders are characterized by a range in phenotypes, the focus of this review is on the specific symptoms and clinical findings that present in the perinatal period, including neurologic, respiratory, endocrine, and cardiovascular manifestations, dysmorphic features, hepatosplenomegaly, skin or ocular involvement, and hydrops fetalis/congenital ascites. A greater awareness of these features may help to reduce misdiagnosis and promote the early detection of lysosomal storage disorders. Implementing therapy at the earliest stage possible is crucial for several of the lysosomal storage disorders; hence, an early appreciation of these disorders by physicians who treat newborns is essential.

Citing Articles

Human-based complex models: their promise and potential for rare disease therapeutics.

Parvatam S, Pistollato F, Marshall L, Furtmann F, Jahagirdar D, Chakraborty Choudhury M Front Cell Dev Biol. 2025; 13:1526306.

PMID: 39931243 PMC: 11807990. DOI: 10.3389/fcell.2025.1526306.

Lysosomal storage disorders: from biology to the clinic with reference to India.

Sheth J, Nair A, Jee B Lancet Reg Health Southeast Asia. 2023; 9:100108.

PMID: 37383036 PMC: 10305895. DOI: 10.1016/j.lansea.2022.100108.

Characterization of pregnancy outcome of women with an offspring with inborn errors of metabolism: A population-based study.

Weiss T, Erez O, Hazan I, Babiev A, Staretz Chacham O Front Genet. 2022; 13:1030361.

PMID: 36437917 PMC: 9683332. DOI: 10.3389/fgene.2022.1030361.

Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders.

Boychuk N, Mulrooney N, Kelly N, Goldenberg A, Silver E, Wasserstein M Int J Neonatal Screen. 2022; 8(4).

PMID: 36412585 PMC: 9680490. DOI: 10.3390/ijns8040059.

Natural history and management of liver dysfunction in lysosomal storage disorders.

Sen Sarma M, Tripathi P World J Hepatol. 2022; 14(10):1844-1861.

PMID: 36340750 PMC: 9627439. DOI: 10.4254/wjh.v14.i10.1844.

References

Lui K, Commens C, Choong R, Jaworski R . Collodion babies with Gaucher's disease. Arch Dis Child. 1988; 63(7):854-6. PMC: 1779077. DOI: 10.1136/adc.63.7.854. View

Uno Y, Taniguchi A, Tanaka E . Histochemical studies in Wolman's disease--report of an autopsy case accompanied with a large amount of milky ascites. Acta Pathol Jpn. 1973; 23(4):779-90. DOI: 10.1111/j.1440-1827.1973.tb02775.x. View

Burch M, Fensom A, Jackson M, Pitts-Tucker T, Congdon P . Multiple sulphatase deficiency presenting at birth. Clin Genet. 1986; 30(5):409-15. DOI: 10.1111/j.1399-0004.1986.tb01899.x. View

Brooks D, McCourt P, Gibson G, Ashton L, Shutter M, Hopwood J . Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients. Am J Hum Genet. 1991; 48(4):710-9. PMC: 1682943. View

Gillett P, Schreiber R, Jevon G, Israel D, Warshawski T, Vallance H . Mucopolysaccharidosis type VII (Sly syndrome) presenting as neonatal cholestasis with hepatosplenomegaly. J Pediatr Gastroenterol Nutr. 2001; 33(2):216-20. DOI: 10.1097/00005176-200108000-00025. View

Kooper A, Janssens P, de Groot A, Liebrand-van Sambeek M, van den Berg C, Tan-Sindhunata G . Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. Clin Chim Acta. 2006; 371(1-2):176-82. DOI: 10.1016/j.cca.2006.03.007. View

Hoyme H, Jones K, Higginbottom M, OBrien J . Presentation of mucopolysaccharidosis VII (beta-glucuronidase deficiency) in infancy. J Med Genet. 1981; 18(3):237-9. PMC: 1048714. DOI: 10.1136/jmg.18.3.237. View

Krivit W . Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin Immunopathol. 2004; 26(1-2):119-32. DOI: 10.1007/s00281-004-0166-2. View

Guertl B, Noehammer C, Hoefler G . Metabolic cardiomyopathies. Int J Exp Pathol. 2001; 81(6):349-72. PMC: 2517748. DOI: 10.1046/j.1365-2613.2000.00186.x. View

10.

Beaudet A, Diferrante N, Ferry G, NICHOLS Jr B, Mullins C . Variation in the phenotypic expression of beta-glucuronidase deficiency. J Pediatr. 1975; 86(3):388-94. DOI: 10.1016/s0022-3476(75)80968-1. View

11.

Hollak C, Vedder A, Linthorst G, Aerts J . Novel therapeutic targets for the treatment of Fabry disease. Expert Opin Ther Targets. 2007; 11(6):821-33. DOI: 10.1517/14728222.11.6.821. View

12.

Sidransky E, Sherer D, Ginns E . Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res. 1992; 32(4):494-8. DOI: 10.1203/00006450-199210000-00023. View

13.

Sarfati R, Hubert A, Dugue-Marechaud M, Biran-Mucignat V, Pierre F, Bonneau D . Prenatal diagnosis of Gaucher's disease type 2. Ultrasonographic, biochemical and histological aspects. Prenat Diagn. 2000; 20(4):340-3. DOI: 10.1002/(sici)1097-0223(200004)20:4<340::aid-pd795>3.0.co;2-n. View

14.

Parenti G, Zuppaldi A, Gabriela Pittis M, Rosaria Tuzzi M, Annunziata I, Meroni G . Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease. Mol Ther. 2007; 15(3):508-14. DOI: 10.1038/sj.mt.6300074. View

15.

Chace D, Kalas T, Naylor E . The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet. 2002; 3:17-45. DOI: 10.1146/annurev.genom.3.022502.103213. View

16.

Saul R, Proud V, Taylor H, Leroy J, Spranger J . Prenatal mucolipidosis type II (I-cell disease) can present as Pacman dysplasia. Am J Med Genet A. 2005; 135(3):328-32. DOI: 10.1002/ajmg.a.30716. View

17.

Ben-Haroush A, Yogev Y, Levit O, Hod M, Kaplan B . Isolated fetal ascites caused by Wolman disease. Ultrasound Obstet Gynecol. 2003; 21(3):297-8. DOI: 10.1002/uog.73. View

18.

Meikle P, Hopwood J . Lysosomal storage disorders: emerging therapeutic options require early diagnosis. Eur J Pediatr. 2003; 162 Suppl 1:S34-7. DOI: 10.1007/s00431-003-1348-y. View

19.

Islam M, Shah G, Sly W . PCR-based restriction fragment length polymorphism and haplotype of the most common mutation L176F in the beta-glucuronidase gene. Genet Test. 2007; 11(1):72-4. DOI: 10.1089/gte.2006.0505. View

20.

Nelson A, Peterson L, Frampton B, Sly W . Mucopolysaccharidosis VII (beta-glucuronidase deficiency) presenting as nonimmune hydrops fetalis. J Pediatr. 1982; 101(4):574-6. DOI: 10.1016/s0022-3476(82)80707-5. View